Global Endocrine Testing Market Size & Outlook, 2025-2030
Global endocrine testing market, 2018-2030 (US$M)
Related Markets
Global endocrine testing market highlights
- The global endocrine testing market generated a revenue of USD 13,157.1 million in 2024 and is expected to reach USD 21,421.4 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 8.5% by 2030.
- In terms of segment, thyroid stimulating hormone (tsh) test accounted for a revenue of USD 3,973.2 million in 2024.
- Insulin Test is the most lucrative test type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 13,157.1 million |
| Market revenue in 2030 | USD 21,421.4 million |
| Growth rate | 8.5% (CAGR from 2025 to 2030) |
| Largest segment | Thyroid stimulating hormone (tsh) test |
| Fastest growing segment | Insulin Test |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Estradiol (E2) Test, Follicle Stimulating Hormone (FSH) Test, Human Chorionic Gonadotropin (hCG) Hormone Test, Luteinizing Hormone (LH) Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Progesterone Test, Testosterone Test, Thyroid Stimulating Hormone (TSH) Test, Prolactin Test, Cortisol Test, Insulin Test |
Other key industry trends
- In terms of revenue, the North America accounted for 40.5% of the global endocrine testing market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, China is the fastest growing regional market and is projected to reach USD 444.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Endocrine Testing Market Scope
Endocrine Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Diasorin SpA | View profile | 3233 | Via Crescentino Snc, Saluggia, Vercelli, Italy, 13040 | https://www.diasoringroup.com |
| Labcorp Holdings Inc | View profile | 67000 | 358 South Main Street, Burlington, NC, United States, 27215 | https://www.labcorp.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| QuidelOrtho Corp | View profile | 7100 | 9975 Summers Ridge Road, San Diego, CA, United States, 92121 | https://www.quidelortho.com |
| Quest Diagnostics Inc | View profile | 48000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | https://www.questdiagnostics.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| BioMerieux SA | View profile | 13982 | Marcy l’Etoile, Lyon, France, 69280 | http://www.biomerieux.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Global endocrine testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to endocrine testing market will help companies and investors design strategic landscapes.
Thyroid stimulating hormone (tsh) test was the largest segment with a revenue share of 30.2% in 2024. Horizon Databook has segmented the Global endocrine testing market based on estradiol (e2) test, follicle stimulating hormone (fsh) test, human chorionic gonadotropin (hcg) hormone test, luteinizing hormone (lh) test, dehydroepiandrosterone sulfate (dheas) test, progesterone test, testosterone test, thyroid stimulating hormone (tsh) test, prolactin test, cortisol test, insulin test covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Endocrine Testing Test Type Outlook (Revenue, USD Million, 2018-2030)
- Estradiol (E2) Test
- Follicle Stimulating Hormone (FSH) Test
- Human Chorionic Gonadotropin (hCG) Hormone Test
- Luteinizing Hormone (LH) Test
- Dehydroepiandrosterone Sulfate (DHEAS) Test
- Progesterone Test
- Testosterone Test
- Thyroid Stimulating Hormone (TSH) Test
- Prolactin Test
- Cortisol Test
- Insulin Test
- Others
- Global Endocrine Testing Technology Outlook (Revenue, USD Million, 2018-2030)
- Tandem Mass Spectrometry
- Immunoassay
- Monoclonal & Polyclonal Antibody Technologies
- Sensor Technology
- Clinical Chemistry
- Others
- Global Endocrine Testing End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals
- Commercial Laboratories
- Ambulatory Care Centers
- Others
Reasons to subscribe to Global endocrine testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global endocrine testing market databook
-
Our clientele includes a mix of endocrine testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global endocrine testing market , including forecasts for subscribers. This global databook contains high-level insights into Global endocrine testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global endocrine testing market size, by regions, 2018-2030 (US$M)
Top 10 countries: Endocrine testing market size, 2024 (US$M)
Global endocrine testing market share, by test type, 2024 & 2030 (%, US$M)
Endocrine testing market: Opportunity assessment by country
Global endocrine testing market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
